ImmunityBio IBRX
NASDAQ IBRX
$8.11 -0.08 (-0.98%)
As of: Sep 4, 2026 · 3:21 PM EDT

ImmunityBio (IBRX) Sales of Property, Plant and Equipment (2018 - 2019)

Analysis

ImmunityBio (IBRX) Sales of Property, Plant and Equipment (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 ImmunityBio 8.45 Bn 8.09 Bn 50.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 200,000.00
Dec 31, 2018 392,000.00